申请人:Temple University-Of The Commonwealth System of Higher Education
公开号:US20180221365A1
公开(公告)日:2018-08-09
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of sigma-2 receptor activity.